1. Zhou, Qingxin, Lin, Meihua, Feng, Xing, Zou, Chang, Zhang, Zhiyong. . Targeting CLK3 inhibits the progression of cholangiocarcinoma by reprogramming nucleotide metabolism. In The Journal of experimental medicine, 217, . doi:10.1084/jem.20191779. https://pubmed.ncbi.nlm.nih.gov/32453420/
2. Virgirinia, Regina Putri, Nakamura, Makoto, Takebayashi-Suzuki, Kimiko, Fatchiyah, Fatchiyah, Suzuki, Atsushi. 2021. The dual-specificity protein kinase Clk3 is essential for Xenopus neural development. In Biochemical and biophysical research communications, 567, 99-105. doi:10.1016/j.bbrc.2021.06.005. https://pubmed.ncbi.nlm.nih.gov/34146908/
3. Li, Hua, Cui, Xichun, Hu, Qiuyue, Chen, Xiaolong, Zhou, Pengli. 2019. CLK3 Is A Direct Target Of miR-144 And Contributes To Aggressive Progression In Hepatocellular Carcinoma. In OncoTargets and therapy, 12, 9201-9213. doi:10.2147/OTT.S224527. https://pubmed.ncbi.nlm.nih.gov/31807004/
4. Cesana, Marcella, Guo, Michael H, Cacchiarelli, Davide, Hirschhorn, Joel N, Daley, George Q. . A CLK3-HMGA2 Alternative Splicing Axis Impacts Human Hematopoietic Stem Cell Molecular Identity throughout Development. In Cell stem cell, 22, 575-588.e7. doi:10.1016/j.stem.2018.03.012. https://pubmed.ncbi.nlm.nih.gov/29625070/
5. Ma, Yulin, Gao, Fei, Liu, Yang. 2024. CLK3 positively promoted colorectal cancer proliferation by activating IL-6/STAT3 signaling. In Experimental cell research, 440, 114132. doi:10.1016/j.yexcr.2024.114132. https://pubmed.ncbi.nlm.nih.gov/38885806/
6. Menegay, H, Moeslein, F, Landreth, G. . The dual specificity protein kinase CLK3 is abundantly expressed in mature mouse spermatozoa. In Experimental cell research, 253, 463-73. doi:. https://pubmed.ncbi.nlm.nih.gov/10585269/
7. Dahal, Subha, Clayton, Kiera, Been, Terek, Parent, Leslie J, Cochrane, Alan. 2022. Opposing roles of CLK SR kinases in controlling HIV-1 gene expression and latency. In Retrovirology, 19, 18. doi:10.1186/s12977-022-00605-4. https://pubmed.ncbi.nlm.nih.gov/35986377/
智鼠故事 
